133 related articles for article (PubMed ID: 11313943)
1. Expression of a down-regulated target, SSeCKS, reverses v-Jun-induced transformation of 10T1/2 murine fibroblasts.
Cohen SB; Waha A; Gelman IH; Vogt PK
Oncogene; 2001 Jan; 20(2):141-6. PubMed ID: 11313943
[TBL] [Abstract][Full Text] [Related]
2. Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis.
Lin X; Gelman IH
Cancer Res; 1997 Jun; 57(11):2304-12. PubMed ID: 9187136
[TBL] [Abstract][Full Text] [Related]
3. Conditional cell transformation by doxycycline-controlled expression of the ASV17 v-jun allele.
Bader AG; Hartl M; Bister K
Virology; 2000 Apr; 270(1):98-110. PubMed ID: 10772983
[TBL] [Abstract][Full Text] [Related]
4. v-Jun targets showing an expression pattern that correlates with the transformed cellular phenotype.
Iacovoni JS; Cohen SB; Berg T; Vogt PK
Oncogene; 2004 Jul; 23(33):5703-6. PubMed ID: 15133497
[TBL] [Abstract][Full Text] [Related]
5. TOJ3, a target of the v-Jun transcription factor, encodes a protein with transforming activity related to human microspherule protein 1 (MCRS1).
Bader AG; Schneider ML; Bister K; Hartl M
Oncogene; 2001 Nov; 20(51):7524-35. PubMed ID: 11709724
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of the extracellular matrix protein SPARC in vSrc- and vJun-transformed chick embryo fibroblasts contributes to tumor formation in vivo.
Vial E; Castellazzi M
Oncogene; 2000 Mar; 19(14):1772-82. PubMed ID: 10777211
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor ATF3 partially transforms chick embryo fibroblasts by promoting growth factor-independent proliferation.
Perez S; Vial E; van Dam H; Castellazzi M
Oncogene; 2001 Mar; 20(9):1135-41. PubMed ID: 11314051
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling by DNA microarray analysis in mouse embryonic fibroblasts transformed by rasV12 mutated protein and the E1A oncogene.
Vasseur S; Malicet C; Calvo EL; Labrie C; Berthezene P; Dagorn JC; Iovanna JL
Mol Cancer; 2003 Mar; 2():19. PubMed ID: 12685932
[TBL] [Abstract][Full Text] [Related]
9. Directed mutation of the basic domain of v-Jun alters DNA binding specificity and abolishes its oncogenic activity in chicken embryo fibroblasts.
Basso J; Briggs J; Findlay C; Bos T
Oncogene; 2000 Oct; 19(42):4876-85. PubMed ID: 11039905
[TBL] [Abstract][Full Text] [Related]
10. Characterization of sarcoma cell lines from v-jun transgenic mice.
Marshall GM; Vanhamme L
Cancer Res; 1993 Feb; 53(3):622-6. PubMed ID: 8425197
[TBL] [Abstract][Full Text] [Related]
11. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer.
Xia W; Unger P; Miller L; Nelson J; Gelman IH
Cancer Res; 2001 Jul; 61(14):5644-51. PubMed ID: 11454719
[TBL] [Abstract][Full Text] [Related]
12. Microarray analysis identifies Autotaxin, a tumour cell motility and angiogenic factor with lysophospholipase D activity, as a specific target of cell transformation by v-Jun.
Black EJ; Clair T; Delrow J; Neiman P; Gillespie DA
Oncogene; 2004 Mar; 23(13):2357-66. PubMed ID: 14691447
[TBL] [Abstract][Full Text] [Related]
13. ras downregulation of protein kinase C mRNA in C3H 10T1/2 fibroblasts.
Fernandes ER; Ashendel CL
Mol Carcinog; 1996 Sep; 17(1):23-34. PubMed ID: 8876672
[TBL] [Abstract][Full Text] [Related]
14. v-Jun stimulates both cdk2 kinase activity and G1/S progression via transcriptional repression of p21 CIP1.
Maclaren A; Clark W; Black EJ; Gregory D; Fujii H; Gillespie DA
Oncogene; 2003 Apr; 22(16):2383-95. PubMed ID: 12717415
[TBL] [Abstract][Full Text] [Related]
15. JAC, a direct target of oncogenic transcription factor Jun, is involved in cell transformation and tumorigenesis.
Hartl M; Reiter F; Bader AG; Castellazzi M; Bister K
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13601-6. PubMed ID: 11698665
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of avian or mouse c-jun in primary chick embryo fibroblasts confers a partially transformed phenotype.
Castellazzi M; Dangy JP; Mechta F; Hirai S; Yaniv M; Samarut J; Lassailly A; Brun G
Oncogene; 1990 Oct; 5(10):1541-7. PubMed ID: 2123532
[TBL] [Abstract][Full Text] [Related]
17. Immortalized fibroblasts from NF-kappaB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor alpha after transformation by v-Ras.
Gapuzan ME; Schmah O; Pollock AD; Hoffmann A; Gilmore TD
Oncogene; 2005 Sep; 24(43):6574-83. PubMed ID: 16027734
[TBL] [Abstract][Full Text] [Related]
18. v-Jun downregulates the SPARC target gene by binding to the proximal promoter indirectly through Sp1/3.
Chamboredon S; Briggs J; Vial E; Hurault J; Galvagni F; Oliviero S; Bos T; Castellazzi M
Oncogene; 2003 Jun; 22(26):4047-61. PubMed ID: 12821939
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha inhibits Schwann cell proliferation by up-regulating Src-suppressed protein kinase C substrate expression.
Tao T; Ji Y; Cheng C; Yang H; Liu H; Sun L; Qin Y; Yang J; Wang H; Shen A
J Neurochem; 2009 Nov; 111(3):647-55. PubMed ID: 19694904
[TBL] [Abstract][Full Text] [Related]
20. Cell transformation by v-Jun deactivates ERK MAP kinase signalling.
Black EJ; Walker M; Clark W; MacLaren A; Gillespie DA
Oncogene; 2002 Sep; 21(42):6540-8. PubMed ID: 12226757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
